- Q1 2024 Neuropace Inc Earnings Call TranscriptMay 08, 2024$12.6 (-5.26%)Earnings
- Q4 2023 Neuropace Inc Earnings Call TranscriptMar 05, 2024$14.2 (+2.38%)Earnings
- Neuropace Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Neuropace Inc Earnings Call TranscriptNov 06, 2023$7.2 (+0.42%)Earnings
- Q2 2023 Neuropace Inc Earnings Call TranscriptAug 08, 2023$4.1Earnings
- Q1 2023 Neuropace Inc Earnings Call TranscriptMay 04, 2023$4.99 (+2.67%)Earnings
- Neuropace Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Q4 2022 Neuropace Inc Earnings Call TranscriptMar 02, 2023$4.2 (-11.21%)Earnings
- Neuropace Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Q3 2022 Neuropace Inc Earnings Call TranscriptNov 08, 2022$2.53 (+8.58%)Earnings
- Neuropace Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 Neuropace Inc Earnings Call TranscriptAug 11, 2022$5.89 (+3.70%)Earnings
- Neuropace Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Q1 2022 Neuropace Inc Earnings Call TranscriptMay 12, 2022$6.26 (+2.96%)Earnings
- Q4 2021 Neuropace Inc Earnings Call TranscriptMar 10, 2022$7.61 (-6.63%)Earnings
- Neuropace Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2022
- Q3 2021 Neuropace Inc Earnings Call TranscriptNov 10, 2021$15.8 (-4.24%)Earnings
- Neuropace Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Q2 2021 Neuropace Inc Earnings Call TranscriptAug 12, 2021$21.66 (-2.56%)Earnings
- Q1 2021 Neuropace Inc Earnings Call TranscriptJun 03, 2021$21.67 (-3.65%)Earnings
Neuropace Inc at JPMorgan Healthcare Conference Transcript
Great. Hey, everyone. Good morning. I'm Lily Lozada, I'm on the medtech research team here at JPMorgan. And I'm happy to have the NeuroPace management team with us here today.
I'll pass it over to CEO, Joel Becker, for a presentation, and then we'll do some Q&A.
Good morning. Thank you, Lily. Thank you to JP Morgan as well for having us. And thanks to all of you for being with us here, bright and early on a Thursday morning, and to everybody joining.
My name is Joel Becker. I'm the President and CEO of NeuroPace. And I'm excited to be here with our leadership team, members of our leadership team, to tell you about who we are and what we do, our current status, and why we're excited about where we're headed. So with that, I'll get right to it.
Please note our disclaimers. And I'll start with who NeuroPace is. It's best defined by our mission. You can see it here. And that is to transform the lives of people suffering
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)